Assessing NOS Uptake With PET Imaging in Lung Inflammation



Status:Completed
Conditions:Pneumonia
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:19 - 44
Updated:7/25/2018
Start Date:May 2014
End Date:February 2018

Use our guide to learn which trials are right for you!

Assessing [18F](+/-)NOS Uptake With PET Imaging in Endotoxin-induced Lung Inflammation

The purpose of this study is to learn more about the basic responses of the lungs to
inflammation using positron emission tomography, or PET, imaging scans of the lungs. PET is a
machine that detects radiation and generates pictures using a donut-shaped scanner similar in
appearance to an x-ray "CAT" or computed tomography (CT) scan or an MRI. Inflammation is the
way our bodies react to irritation or injury, and involves red, warm, and often painful
swelling of the affected tissue. An enzyme called inducible nitric oxide synthase (iNOS)
contributes to the development of lung inflammation.

The investigators plan to use three radioactive tracers to produce the PET images for
measuring lung inflammation: [18F](+/-)NOS (the F stands for fluorine and NOS stands for
Nitric Oxide Synthase, which targets iNOS), O-15 carbon monoxide ([15O]CO), and O-15 water
([15O]H2O). The NOS tracer gives information specifically about lung inflammation, while the
carbon monoxide and water tracers give information about whether the lung inflammation causes
more blood or water to be retained in the area of lung inflammation.

In order to show that [18F](+/-)NOS-PET is related to the amount of inflammation, the
investigators first need to create a state of controlled lung inflammation that can be
measured and quantified. "Controlled lung inflammation" means a reaction in the lungs that is
similar to that which occurs during lung infection (increased respiratory secretions and
cough). It is "controlled" because the investigators will not be using anything alive or
contagious (it does not spread from one part of the body to another, and cannot spread to
another person), and a small area in only one lung will be affected. In order to created this
state of controlled lung inflammation, the investigators plan to place a small amount of a
purified bacterial substance called endotoxin into a single small section of the lung using a
bronchoscope (a long, flexible narrow tube that is passed through the mouth into the airways
of the lung). This use of endotoxin is considered investigational, and the investigators have
received permission from the FDA to use endotoxin in this research study.

Inclusion Criteria:

- Healthy man or woman, any race or ethnicity, age 19-44 years old

- Screening FEV1 and FVC greater than or equal to 90% of predicted

- Screening oxygen saturation by pulse oximetry greater than or equal to 97% on room air

- Capable of lying still and supine with arms raised above the head within PET/CT
scanner for 2-2.5 hours

- Capable of following instructions for breathing protocol during CT portion of PET/CT
scans

- Able and willing to give informed consent

- Body Mass Index (BMI) < 35

Exclusion Criteria:

- Pregnancy (confirmed by qualitative serum hCG pregnancy test)

- Lactation

- History of cardiopulmonary disease

- Currently taking any prescription medications

- History of tobacco use or illicit drug use within the past year

- Presence of implanted electronic medical device

- Enrollment in another research study of an investigational drug

- Known allergy to both trimethoprim/sulfamethoxazole and amoxicillin, Penicillin,
Lidocaine, Demerol, Versed, and/or Fentanyl

- Inability to lie flat for 2-2.5 hours for PET/CT scans or follow breathing protocol
instructions for the CT portion of the PET/CT

- Prior research-related radiation exposure within the past year such that participation
in this study would result in exposures that exceed the limits as defined by the FDA
RDRC regulations (21 CFR 361.1)
We found this trial at
1
site
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials